These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 33521013)

  • 1. COVID-19 With Preexisting Hypercoagulability Digestive Disease.
    Jiang M; Mu J; Shen S; Zhang H
    Front Med (Lausanne); 2020; 7():587350. PubMed ID: 33521013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal System: COVID-19 and Potential Mechanisms Associated with Coagulopathy.
    Furfaro F; Gabbiadini R; D'Amico F; Zilli A; Dal Buono A; Allocca M; Fiorino G; Danese S
    Curr Drug Targets; 2022; 23(17):1611-1619. PubMed ID: 36154571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and the Digestive System.
    Ma C; Cong Y; Zhang H
    Am J Gastroenterol; 2020 Jul; 115(7):1003-1006. PubMed ID: 32618648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications.
    Haimei MA
    Clin Appl Thromb Hemost; 2020; 26():1076029620944497. PubMed ID: 32722927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic and Hypercoagulability Complications of COVID-19: An Update.
    Shibeeb S; Ahmad MN
    J Blood Med; 2021; 12():785-793. PubMed ID: 34512059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and Hypercoagulability: A Review.
    Kichloo A; Dettloff K; Aljadah M; Albosta M; Jamal S; Singh J; Wani F; Kumar A; Vallabhaneni S; Khan MZ
    Clin Appl Thromb Hemost; 2020; 26():1076029620962853. PubMed ID: 33074732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant renal and splenic infarctions in a COVID-19-patient with a catastrophic thrombotic syndrome.
    Brem FL; Tayef TAA; Rasras H; Mahi OE; Ouafi NE; Zakaria B
    Radiol Case Rep; 2022 Oct; 17(10):4030-4033. PubMed ID: 35999857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Disease and Hypercoagulability Leading to Acute Ischemic Stroke.
    Mullaguri N; Hepburn M; Gebel JM; Itrat A; George P; Newey CR
    Neurohospitalist; 2021 Apr; 11(2):131-136. PubMed ID: 33791056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digestive system involvement of infections with SARS-CoV-2 and other coronaviruses: Clinical manifestations and potential mechanisms.
    Zhan GF; Wang Y; Yang N; Luo AL; Li SY
    World J Gastroenterol; 2021 Feb; 27(7):561-575. PubMed ID: 33642829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and coagulopathy.
    Sarkar M; Madabhavi IV; Quy PN; Govindagoudar MB
    Clin Respir J; 2021 Dec; 15(12):1259-1274. PubMed ID: 34399021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and Thromboinflammation: Is There a Role for Statins?
    Ferrari F; Martins VM; Teixeira M; Santos RD; Stein R
    Clinics (Sao Paulo); 2021; 76():e2518. PubMed ID: 33787678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine.
    Vrachatis DA; Papathanasiou KA; Giotaki SG; Raisakis K; Kossyvakis C; Kaoukis A; Kolokathis F; Deftereos G; Iliodromitis KE; Avramides D; Bogossian H; Siasos G; Giannopoulos G; Reimers B; Lansky A; Tardif JC; Deftereos S
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019.
    Wada H; Shiraki K; Shimpo H; Shimaoka M; Iba T; Suzuki-Inoue K
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous Thrombosis and SARS-CoV-2.
    Zdanyte M; Rath D; Gawaz M; Geisler T
    Hamostaseologie; 2022 Aug; 42(4):240-247. PubMed ID: 34879422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital Bleeding Disorders and COVID-19 - An Emphasis on the Role of Thrombosis as One of the Main Causes of Morbidity and Mortality in COVID-19.
    Dorgalaleh A; Narouei F; Asadi M; Khamsi HM; Gholami MS
    Cardiovasc Hematol Disord Drug Targets; 2022; 22(2):83-86. PubMed ID: 35702769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
    Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interplay between hypovitaminosis D and the immune dysfunction in the arteriovenous thrombotic complications of the sever coronavirus disease 2019 (COVID-19) infection.
    AlNafea HM; Korish AA
    Blood Coagul Fibrinolysis; 2023 Apr; 34(3):129-137. PubMed ID: 36966750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Thrombotic Complications in COVID-19: An Update.
    Hajra A; Mathai SV; Ball S; Bandyopadhyay D; Veyseh M; Chakraborty S; Lavie CJ; Aronow WS
    Drugs; 2020 Oct; 80(15):1553-1562. PubMed ID: 32803670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection.
    Boccatonda A; Campello E; Simion C; Simioni P
    Expert Rev Hematol; 2023; 16(12):1035-1048. PubMed ID: 38018136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.